Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Eli Lilly
LLY
|
+$788M |
| 2 |
Uber
UBER
|
+$600M |
| 3 |
Netflix
NFLX
|
+$441M |
| 4 |
Goldman Sachs
GS
|
+$414M |
| 5 |
Microsoft
MSFT
|
+$412M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
+$786M |
| 2 |
Nike
NKE
|
+$750M |
| 3 |
Walt Disney
DIS
|
+$743M |
| 4 |
Edwards Lifesciences
EW
|
+$702M |
| 5 |
Illumina
ILMN
|
+$618M |
Sector Composition
| 1 | Technology | 30.69% |
| 2 | Consumer Discretionary | 19.06% |
| 3 | Healthcare | 13.05% |
| 4 | Communication Services | 12.23% |
| 5 | Financials | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Integra LifeSciences
IART
$1.22B
| $29.9M | 0.04% |
670,284
-120,394
| -15% | -$5.38M |
|
|
AVLR
202
DELISTED
Avalara, Inc.
AVLR
| $29.7M | 0.04% |
398,303
+170,436
| +75% | +$12.7M |
|
203
Roper Technologies
ROP
$56.3B
| $29.4M | 0.04% |
94,441
-24,019
| -20% | -$7.49M |
|
204
Varonis Systems
VRNS
$6.45B
| $29.2M | 0.04% |
1,373,934
+172,380
| +14% | +$3.66M |
|
205
Capital One
COF
$141B
| $29.2M | 0.04% |
578,254
-381,139
| -40% | -$19.2M |
|
206
Church & Dwight Co
CHD
$23B
| $29.1M | 0.04% |
452,758
+198
| +0% | +$12.7K |
|
207
Biogen
BIIB
$20.7B
| $28.9M | 0.04% |
91,368
+89,297
| +4,312% | +$28.3M |
|
208
Q2 Holdings
QTWO
$5.25B
| $28.3M | 0.03% |
479,418
+173,019
| +56% | +$10.2M |
|
209
East-West Bancorp
EWBC
$15.1B
| $28.2M | 0.03% |
1,095,035
-820,724
| -43% | -$21.1M |
|
|
TPTX
210
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $28.1M | 0.03% |
628,748
+83,298
| +15% | +$3.72M |
|
211
Suncor Energy
SU
$48.8B
| $27.7M | 0.03% |
1,750,754
-161,718
| -8% | -$2.56M |
|
212
GFL Environmental
GFL
$17.2B
| $27.5M | 0.03% |
+1,826,529
| New | +$27.5M |
|
213
Cheniere Energy
LNG
$51.3B
| $27.3M | 0.03% |
814,926
-877,055
| -52% | -$29.4M |
|
|
LVGO
214
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $27.1M | 0.03% |
950,333
+215,621
| +29% | +$6.15M |
|
|
EVBG
215
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $27.1M | 0.03% |
254,488
+3,371
| +1% | +$359K |
|
|
CXP
216
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $26.4M | 0.03% |
2,113,667
+38,612
| +2% | +$483K |
|
|
WPX
217
DELISTED
WPX Energy, Inc.
WPX
| $26.4M | 0.03% |
8,656,051
-768,553
| -8% | -$2.34M |
|
218
Molina Healthcare
MOH
$9.51B
| $26.2M | 0.03% |
+187,642
| New | +$26.2M |
|
219
IDEX
IEX
$12.4B
| $26.2M | 0.03% |
189,692
-14,759
| -7% | -$2.04M |
|
|
PRNB
220
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $25.7M | 0.03% |
433,306
+111,018
| +34% | +$6.59M |
|
221
Trane Technologies
TT
$92.3B
| $25.7M | 0.03% |
310,635
+24,252
| +8% | +$2M |
|
|
RVNC
222
DELISTED
Revance Therapeutics, Inc.
RVNC
| $25.2M | 0.03% |
+1,702,524
| New | +$25.2M |
|
223
National Storage Affiliates Trust
NSA
$2.51B
| $25.1M | 0.03% |
846,750
-92,906
| -10% | -$2.75M |
|
224
Bright Horizons
BFAM
$6.62B
| $25M | 0.03% |
245,552
-16,449
| -6% | -$1.68M |
|
|
AAMI
225
Acadian Asset Management Inc.
AAMI
$1.61B
| $25M | 0.03% |
3,912,779
-32,600
| -0.8% | -$208K |
|